292 results
Page 9 of 15
8-K
EX-99
njat14aeej3mkho9ha81
26 Apr 12
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
fzv5k
2 Apr 12
GlaxoSmithKline to increase its ownership in Theravance
12:00am
DEFA14A
EX-99.1
1sgserv2 7pr
2 Apr 12
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
i9tvm9 6xwt204rcwmr
23 Mar 12
Other Events
12:00am
8-K
wsnq8xtgr8kkf5iio
23 Mar 12
Other Events
12:00am
8-K
17pz6qzw2eul
16 Feb 12
Regulation FD Disclosure
12:00am
8-K
EX-99
6l7b 2pq653zov8q7p
9 Feb 12
Results of Operations and Financial Condition
12:00am
8-K
511tn se8a91
9 Jan 12
Other Events
12:00am
8-K
EX-99
npvg4a037d68qzvt
9 Jan 12
Other Events
12:00am
8-K
jmt8e5kyyf
27 Oct 11
Other Events
12:00am
8-K
EX-99
m678x6cklp8
27 Oct 11
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
zf3 ypn5m
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
rjyvzcgjzi86tb71
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99.3
7y9ep
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99.2
qg58ww2kvgd
26 Sep 11
Dose-related efficacy of GSK573719, a new long-acting muscarinic receptor antagonist (LAMA) offering sustained 24-hour bronchodilation in COPD
12:00am
8-K
EX-99
vs5ow5qwincgsua
28 Jul 11
Results of Operations and Financial Condition
12:00am